Get started
Author

Susanne Peschel

Observed names: Peschel, Susanne, S Peschel, S. Peschel, S., Peschel
OpenAlex ID: A5045117077
PIK3CA-mutations in breast cancer
2022 · Kristin Reinhardt, Kathrin Stückrath, et al. · Breast Cancer Research and Treatment · 131
PDF
Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors
2017 · Stephan Bernhardt, Michaela Bayerlová, et al. · Breast Cancer Research · 104
PDF
Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers
2022 · O. Ortmann, J.-U. Blohmer, et al. · Journal of Cancer Research and Clinical Oncology · 56
PDF
Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping
2021 · Carolin Hartung, Martin Porsch, et al. · Breast Care · 20
Trastuzumab treatment of patients with early, HER2-positive breast cancer in 17 certified German breast cancer centers
2021 · Nora Tabea Sibert, Simone Wesselmann, et al. · Journal of Cancer Research and Clinical Oncology · 9
Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients
2022 · Kathleen Schüler, Daniel Bethmann, et al. · Diagnostics · 8
PDF
Use of social service counseling by cancer patients: an analysis of quality assurance data of 6339 breast cancer patients from 13 certified centers in Germany treated between 2015 and 2017
2021 · Clara Breidenbach, Simone Wesselmann, et al. · BMC Cancer · 8
PDF
Specific allelic variants of SNPs in the MDM2 and MDMX genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients
2019 · Marcus Bauer, Eva Johanna Kantelhardt, et al. · Oncotarget · 8
PDF
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study
2025 · Thorsten Kühn, Maggie Banys-Paluchowski, et al. · British journal of surgery · 6
Prädiktoren der Inanspruchnahme und des Beginns einer onkologischen Rehabilitation nach Brustkrebs
2021 · Dorothee Noeres, Stefanie Sperlich, et al. · Die Rehabilitation · 6
Prospective validation of the prognostic and predictive impact of uPA/PAI-1 in early breast cancer
2025 · Vanessa Wieder, Julia Engel, et al. · Breast Cancer Research and Treatment · 3
PDF
Prognostic and predictive impact of NOTCH1 in early breast cancer
2024 · Julia Engel, Vanessa Wieder, et al. · Breast Cancer Research and Treatment · 3
PDF
Correction: Prognostic and predictive impact of NOTCH1 in early breast cancer
2024 · Julia Engel, Vanessa Wieder, et al. · Breast Cancer Research and Treatment · 1
PDF
Abstract P3-11-07: HER2 determination by ERBB2-mRNA expression analysis
2025 · Martina Vetter, Lara Bender, et al. · Clinical Cancer Research
295P ESR1, PGR, ERBB2, MKI67 single gene analysis in neoadjuvant-treated early breast cancer patients
2023 · R. Spiller, T. Bracht, et al. · Annals of Oncology
PDF
297P Prognostic and predictive impact of NOTCH1 in early breast cancer
2023 · J. Engel, V. Wieder, et al. · Annals of Oncology
PDF
284P Prognostic and predictive impact of uPA/PAI-1 in early breast cancer
2023 · V. Wieder, J. Engel, et al. · Annals of Oncology
PDF
313P Intrinsic subtypes in a cohort of early breast cancer patients
2023 · T. Bracht, R. Spiller, et al. · Annals of Oncology
PDF
Klinische Praxis und Ergebnisse der neoadjuvanten Chemotherapie bei frühem Brustkrebs
2022 · Olaf Ortmann, J.-U. Blohmer, et al. · Forum
Abstract P4-07-15: Tumor infiltrating lymphocytes as a prognostic factor
2022 · Kathleen Schüler, Daniel Bethmann, et al. · Cancer Research
Supplementary Material for: Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping
2021 · C., Hartung, M., Porsch, et al. · Figshare
Abstract P4-06-13: Prospective analysis of molecular subtypes in triple negative breast cancer
2020 · Martina Vetter, Carolin Hartung, et al. · Cancer Research
Abstract P2-05-12: The ASCO-recommended prognostic factors uPA/PAI-1 in a multicenter cohort study (PiA)
2017 · M Vetter, C Hartung, et al. · Cancer Research
Additional file 5: Table S3. of Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors
2017 · Bernhardt, Stephan, BayerlovĂĄ, Michaela, et al. · Figshare
Additional file 8: Table S6. of Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors
2017 · Bernhardt, Stephan, BayerlovĂĄ, Michaela, et al. · Figshare
Works count: 38
Citation count: 363
H-index: 8
I10-index: 4
Year
Topic
Type